Myopia Control

Help keep your child’s prescription from getting worse with OthoK.

Help keep your child’s prescription from getting worse with OthoK.


Does Your Child’s Prescription Seems to Get Worse All the Time?

It’s more than an inconvenience; it’s a serious risk to your child’s eyes and vision.  If your child’s prescription for nearsightedness is getting worse all the time your child has what is called progressive myopia.  This condition is much more than just needing stronger and stronger glasses or contacts. Myopia puts your child at risk for several serious and potentially vision threatening eye conditions later in life.  These risks include myopic macular degeneration, retinal detachment and glaucoma.

The more advanced the progression, the greater the risks associated with your child’s myopia.  However, the research is now showing that any amount of myopia is potentially dangerous. This is why OrthoK is recommended for even small amounts of myopia.

At Curts & Reed Optometry, we specialize in providing Olathe and the greater Kansas City area with a specialized treatment plan to control the progression of your child’s myopia.  By stopping or even slowing down the progression of myopia, we greatly reduce the long-term risks to best ensure that your child enjoys seeing the world with healthy eyes throughout his or her adult life.

What is Myopia Control?

In recent years, a number of advanced methods have been developed to control myopia.  The goal of these treatments are to slow or even stop the progression of myopia. Unlike with glasses or regular contact lenses that actually make your child’s myopia worse.  At Curts and Reed Optometry, Dr. Curts will begin by performing a full assessment of your child’s myopia. She will then recommend a personalized treatment plan to slow or even stop your child’s myopia from getting worse.  This will in turn will minimize the risks to your child’s long-term vision performance.

Which Treatments Are Available For Myopia?  How Does Myopia Control Work?

There are three main treatments that are used to control myopia. These are:

  • Orthokeratology (OrthoK)

  • Specialized soft multifocal contact lenses

  • Atropine

Each treatment option has its advantages and disadvantages. After we assess your child’s myopia, we will discuss all the options and develop a personalized treatment plan that works best for you and your child’s needs.

Controlling Myopia With OrthoK

OrthoK, or, orthokeratology goes by many names.

  • Gentle Shaping Vision System (GVSS)

  • Corneal Reshaping Therapy (CRT)

  • Vision Shaping Therapy (VST)

  • Corneal Molding (CM)

All of these treatment names are more or less the same thing. OrthoK is a FDA approved non-surgical treatment method of vision correction that has been safely used for over 20 years.  A rigid contact lens or retainer is custom-made for your child’s eyes by our Myopia Control experts and is worn at night by your child. As your child sleeps, the lenses gently and painlessly reshape the cornea of the eyes. This corrects their vision during the day and your child possibly will not need glasses or contact lenses during the day at all — an especially appealing option for kids who don’t want to wear glasses or young athletes.  In order to maintain clear vision on a daily basis, the retainer lenses need to be worn every night, but some patients can have clear vision only wearing them every other night.

The biggest benefit is that OrthoK has been proven to be highly effective at slowing and halting the progression of myopia, so it is also protecting your child’s adult vision while freeing them from glasses in the here and now.

OrthoK allows adults and children alike to wake up with their vision corrected, without the need to wear glasses or day-time contacts. For children, OrthoK has an added benefit of slowing and even stopping the progression of myopia.

Controlling Myopia With Multifocal Soft Contact Lenses

Another way of controlling myopia is by wearing a specialized soft, multifocal contact lenses, which your child wears during the day.  

Controlling Myopia With Atropine Therapy

Atropine is a medicated drop, similar to the drop used to dilate the eyes for an exam. In a very small concentration, atropine has been found to be highly effective at slowing myopia with minimal side effects. Atropine therapy is safe, and an ideal choice for children who are too young to begin OrthoK. Atropine can also be used in combined with other methods of myopia control. Newer research is even showing success at reducing the risk of developing myopia with pre-myopic patients.

When Should My Child Start Myopia Control?

The stronger the myopic prescription, the greater the risk for vision threatening eye diseases. Therefore, our Myopia Control Experts recommend starting Myopia Control as soon as myopia is detected. It’s important to stop or slow the myopia before your child’s vision or eyes get worse. This is the only way to minimize the risks and it also has the significant benefit of keeping your child from needing a stronger and stronger prescription every year.

Meet Our Myopia Control Eye Doctor

 Dr. Curts is passionate about myopia control. She started wearing glasses in the second grade and is now an adult with high myopia. She understands the challenges and risks that being very nearsighted can cause. This is why she has dedicated her career to helping children correct their myopia in order to slow down it’s progression or stop it from getting worse. Dr. Curts also wears OrthoK retainers to correct her own vision while she sleeps. So she not only prescribes OrthoK for your children, but she does it with them.

Research Links For Myopia Control

High myopia as a risk factor in primary open angle glaucoma

Time outdoors and the prevention of Myopia

Myopia and associated pathological complications

Five-Year Clinical Trial on Atropine for the Treatment of Myopia:  Myopia Control with Atropine 0.01% Eyedrops

Outdoor Activity during Class Recess Reduces Myopia Onset and Progression in School Children

Orthokeratology to control myopia progression:  a meta-analysis

Misight presented at BCLA 2017:  myopia care